đź“‹ FDA Reference

Ekos Micro-Infusion System

Ekos Corporation

Contact a rep Compare similar devices

Summary: The Ekos Micro-Infusion System is a medical device used for mechanical thrombectomy in venous systems. It is primarily utilized by interventional radiologists and vascular specialists to treat patients with blood clots.

FDA Clearance Information

Pathway ? 510(k)
Number ? K051225 ↗
Decision Date ? June 10, 2005
Product Code ? NUI
Device Class ? Class 2
Evidence ? 35 studies

The Ekos Micro-Infusion System was cleared through the FDA 510(k) pathway on June 10, 2005. Manufactured by Ekos, it is classified as a Class 2 medical device under product code NUI.

What It Is

The Ekos Micro-Infusion System is a catheter-based device designed to deliver thrombolytic drugs directly to blood clots while simultaneously using ultrasound energy to enhance drug penetration and clot dissolution. This dual-action approach allows for more efficient and targeted clot removal, reducing the risk of complications associated with systemic thrombolysis.

FDA-Cleared Indications

  • Treatment of venous thrombosis using catheter-directed infusion of thrombolytic medication with ultrasound assistance.
  • Use in selected patients when targeted clot treatment is clinically indicated and appropriate thrombolytic therapy is prescribed.

Clinical Applications

  • Catheter-directed thrombolytic treatment of selected lower-extremity deep vein thrombosis.
  • Catheter-directed thrombolytic treatment of selected pulmonary embolism involving the pulmonary arteries.
  • Ultrasound-assisted delivery of thrombolytic medication directly within a venous blood clot.
  • Treatment of acute venous thrombosis in a hospital or interventional procedure setting when rapid clot reduction is needed.

Reported off-label uses

  • Use in selected thrombosed dialysis grafts or fistulas has been described for catheter-directed thrombolytic treatment, but the specific device labeling and local regulatory requirements should be reviewed before use.
  • Use in other peripheral venous or arterial thrombotic conditions may be reported in clinical practice, but is not necessarily covered by the FDA-cleared indication.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The system uses a catheter with an ultrasound element and infusion ports; the available catheter size and treatment length must match the target vessel and clot.
  • It is used with an appropriate thrombolytic medication selected and dosed by the treating clinician; drug compatibility and preparation instructions must be followed.
  • Placement is performed under imaging guidance, commonly fluoroscopy, through venous access such as the femoral or internal jugular vein.
  • Important risks include bleeding, access-site complications, clot migration or embolization, infection, contrast reaction, vessel injury and complications from thrombolytic medication.
  • MRI safety depends on the specific catheter and system components. The exact model should be checked in the current manufacturer instructions before MRI; an indwelling treatment catheter is generally not assumed to be MRI safe without verification.

Related Literature

The Interventional Management of Stroke (IMS) III Trial investigated the efficacy of endovascular therapy in stroke management. Although specific details of the study are not available, it likely explored the use of devices like the Ekos Micro-Infusion System in improving outcomes for stroke patients. Limitations may include the lack of detailed results and the study's focus on arterial rather than venous applications.

Procedures that use this device

Linked Studies (20)

PubMed • 2026

Real-world clinical outcomes of EKOS catheter-directed thrombolysis versus systemic alteplase in acute pulmonary embolism: a retrospective cohort study.

Frontiers in pharmacology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Novel Phase Shift Microbubbles, MVT-101, Enhance Sonothrombolysis in a Porcine Model of Deep Vein Thrombosis.

Nanotheranostics

View Source →
PubMed • 2024

[Interventional therapy of pulmonary embolism - update].

Deutsche medizinische Wochenschrift (1946)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Initiating and imaging cavitation from infused echo contrast agents through the EkoSonic catheter.

Scientific reports

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

[Ultrasound-accelerated thrombolysis. Initial experience in patients with contraindications to systemic thrombolysis].

Revista medica del Instituto Mexicano del Seguro Social

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Quantifying the Effect of Acoustic Parameters on Temporal and Spatial Cavitation Activity: Gauging Cavitation Dose.

Ultrasound in medicine & biology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Treatment With EkoSonic™ Endovascular System (EKOS®) of Massive Pulmonary Thrombosis Following Recovery From COVID-19 Infection.

Cureus

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

EkoSonic™ Endovascular System-Directed Thrombolysis in a Patient With COVID-19 Infection Presenting With Bilateral Large Pulmonary Embolism Causing Right Ventricular Strain: A Case Report.

Cureus

Case Report View Source →
PubMed • 2022

Analysis of pulmonary embolism patients treated with EkoSonic™ endovascular system.

Turk gogus kalp damar cerrahisi dergisi

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Successful Thrombolysis of Acute Upper Limb Ischemia Using Ekosonic Endovascular System Ultrasound Catheter in a Patient With Atrial Fibrillation.

Cardiovascular revascularization medicine : including molecular interventions

Case Series View Source →
PubMed • 2022

Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis.

Blood advances

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Massive pulmonary embolism in patients with extreme bleeding risk: a case series on the successful use of ultrasound-assisted, catheter directed thrombolysis in a district general hospital.

Journal of thrombosis and thrombolysis

Case Series View Source →
PubMed • 2022

EKOS™ Jena Experience: Safety, Feasibility, and Midterm Outcomes of Percutaneous Ultrasound-Assisted Catheter-Directed Thrombolysis in Patients with Intermediate-High-Risk or High-Risk Pulmonary Embolism.

Canadian respiratory journal

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Cavitation Emissions Nucleated by Definity Infused through an EkoSonic Catheter in a Flow Phantom.

Ultrasound in medicine & biology

View Source →
PubMed • 2021

Hemodynamic Effects of Ultrasound-Assisted, Catheter-Directed, Very Low-Dose, Short-Time Duration Thrombolysis in Acute Intermediate-High Risk Pulmonary Embolism (from the EKOS-PL Study).

The American journal of cardiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

Ekosonic Endovascular System (EKOS) in a trauma patient with intracranial bleed, recent major surgery, and massive pulmonary embolus: A case report.

Radiology case reports

Case Report View Source →
PubMed • 2020

EkoSonic Thrombolysis as a Therapeutic Adjunct in Venous Occlusive Disease.

The International journal of angiology : official publication of the International College of Angiology, Inc

Retrospective|case Series View Source →
PubMed • 2020

The Role of EkoSonic Endovascular System or EKOS® in Pulmonary Embolism.

Cureus

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

EkoSonic® endovascular system and other catheter-directed treatment reperfusion strategies for acute pulmonary embolism: overview of efficacy and safety outcomes.

Expert review of medical devices

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

Real-World Outcomes of EKOS Ultrasound-Enhanced Catheter-Directed Thrombolysis for Acute Limb Ischemia.

Annals of vascular surgery

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is the Ekos Micro-Infusion System used for?

It is used for the treatment of venous thrombosis, specifically deep vein thrombosis and pulmonary embolism.

What specialties typically use this device?

Interventional radiologists and vascular surgeons typically use this device.

What are the FDA-cleared indications?

The device is indicated for the treatment of venous thrombosis, including deep vein thrombosis and pulmonary embolism.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you